Introduction 100%

visadeewa
Introduction100.docx

Introduction 100% Plagiarized

Bacterial meningitis is a severe, life-threatening infection of the central nervous system that requires immediate medical attention. Even with appropriate treatment, morbidity and mortality can be substantial. Clinicians need to recognize the clinical signs and symptoms of meningitis and understand its management and prevention. From Senegal to Ethiopia, a wave of devastating illness sweeps across the 26 countries of Africa's "Meningitis Belt" every 5 to 14 years. Meningitis is one of the most feared diseases in Africa Glassman, A., & Temin, M., 2016). The infection, which makes the protective membranes around the brain and neck painfully swell, is challenging to diagnose and swift to kill. Common symptoms such as fever, headache, and neck stiffness may be missed or altogether absent. One could go to sleep healthy and never wake up. When untreated, meningitis fatality rates can soar to more than 80 percent and, and even with treatment, 5 to 10 percent of infected individuals die, often within hours of symptom onset Glassman, A., & Temin, M., 2016).

The Problem 20% Plagiarized

At that time, what appears to be the problem is the PS vaccine that has a drawback; it provides just two to three years of protection, and offer no little protection to babies and young children. Also, it failed to prevent transmission within the dense population and cost more than many of these counties can afford.

According to the textbook "millions saved" if the PS vaccine that has a drawback; it provides just two to three years of protection, and offer no little protection to babies and young children. Also, it failed to prevent transmission within the dense population and cost more than many of these counties can afford. Also, if a country like Burkina Faso spends 5 percent of the country's health budget fighting meningitis, they face numerous health challenges such as malaria, TB, VVF, HIV, and more. With the availability of PS vaccine tell so much on how ineffective is the PS vaccine. Meanwhile, the PS vaccine offers no little protection on babies and young children infected or may be infected. Likewise, it fails to prevent transmission with the dense population that makes PS vaccine much more ineffective, which shows the vulnerability of the babies and the young children prone to die by meningitis in African "Belt." According to the textbook, "million saved" between 1996-97 meningitis becomes the most massive epidemic on record resulted in over 250,000 cases and 25,000 or 1 in 10 deaths in the "Belt," which presume babies and young children has the highest numbers of death (Glassman, A., & Temin, M., 2016).

Issues to be addressed 20% Plagiarized

The immediate issues addressed by an intervention strategy are PS vaccine, the use of technology in informing the general population, and how to gain the trust of communities with the non-effectiveness PS vaccine and behavioral change by cities in the "Belt." First, the PS vaccine's failure to cover both babies, young children, and adults not protected for a more extended period of years. A new vaccine must cover both babies, young children, and for a longer duration. For example, the polio vaccine is taken once in a lifetime. Second, the use of electronic media, social media, community leaders, and activists promotes and informs the general population. The distrust created by the PS vaccine in the mind communities and the general public of the "Belt." Regaining the trust of the general population needs both government and private organizations and agencies. Lastly, the theories methods that will help with behavioral change by the rural dweller's perception regarding vaccination.

Reference

Glassman, A., & Temin, M. (2016). Millions Saved: New cases of proven success in global health (3rd ed.). Washington DC: Center for Global Development.

Glassman, A., & Temin, M. (n.d.). Eliminating Meningitis Across Africa's Meningitis Belt. Retrieved June 23, 2020, from http://millionssaved.cgdev.org/case-studies/eliminating-meningitis-across-africas-meningitis-belt